{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:16:44Z","timestamp":1788344204503,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21572279"],"award-info":[{"award-number":["21572279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877134"],"award-info":[{"award-number":["21877134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602955"],"award-info":[{"award-number":["81602955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703341"],"award-info":[{"award-number":["81703341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013137","name":"Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.apsb.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T11:49:33Z","timestamp":1564573773000},"page":"327-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents"],"prefix":"10.1016","volume":"10","author":[{"given":"Senling","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2019.07.007_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.apsb.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.apsb.2019.07.007_bib3","first-page":"107","article-title":"Optimization of cancer treatment through overcoming drug resistance","volume":"1","author":"Elshimali","year":"2018","journal-title":"J Cancer Res Oncobiol"},{"key":"10.1016\/j.apsb.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance p-glycoprotein: time for a change of strategy?.","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.apsb.2018.12.006","article-title":"Secalonic acid D induces cell apoptosis in both sensitive and ABCG2-overexpressing multidrug resistant cancer cells through upregulating c-Jun expression","volume":"9","author":"Zhang","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.bmc.2018.10.027","article-title":"Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR)","volume":"26","author":"Chang","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2019.07.007_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.apsb.2018.10.001","article-title":"The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Wen","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2016.02.013","article-title":"Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in\u00a0vivo","volume":"1636","author":"Zhang","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2019.07.007_bib9","first-page":"5059","article-title":"Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice","volume":"60","author":"Murakami","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.1038\/srep18789","article-title":"Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells","volume":"5","author":"Ma","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2013.05.014","article-title":"Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects","volume":"49","author":"Onoue","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.apsb.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1039\/c0cc04936k","article-title":"PET Imaging of nobiletin based on a practical total synthesis","volume":"47","author":"Asakawa","year":"2011","journal-title":"Chem Commun"},{"key":"10.1016\/j.apsb.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1007\/s11164-014-1917-x","article-title":"A ligand-free, powerful, and practical method for methoxylation of unactivated aryl bromides by use of the CuCl\/HCOOMe\/MeONa\/MeOH system","volume":"41","author":"Guo","year":"2015","journal-title":"Res Chem Intermed"},{"key":"10.1016\/j.apsb.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"11796","DOI":"10.1039\/c2cc37015h","article-title":"A concise synthesis of 3-aroylflavones via lewis base 9-azajulolidine-catalyzed tandem acyl transfer-cyclization","volume":"48","author":"Yoshida","year":"2012","journal-title":"Chem Commun"},{"key":"10.1016\/j.apsb.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1016\/j.tet.2015.07.058","article-title":"Synthesis and cyclisation studies of (E)-2-Aryl-1-methyl-3-styrylquinolin-4(1H)-ones","volume":"71","author":"Rocha","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.apsb.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/np3003468","article-title":"Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in Citrus plants","volume":"75","author":"Weso\u0142owska","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2019.07.007_bib17","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1021\/acs.jmedchem.5b00230","article-title":"Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy","volume":"58","author":"Martins","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/jm021099i","article-title":"Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues","volume":"46","author":"Hadjeri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2019.07.007_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00280-007-0449-0","article-title":"Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model","volume":"60","author":"Vassileva","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.apsb.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.fitote.2018.02.025","article-title":"Sensitization of tumor cells to chemotherapy by natural products: a systematic review of preclinical data and molecular mechanisms","volume":"129","author":"De Oliveira J\u00fanior","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.apsb.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"2918796","DOI":"10.1155\/2016\/2918796","article-title":"The multifunctional effects of nobiletin and its metabolites in\u00a0vivo and in\u00a0vitro","volume":"2016","author":"Huang","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.apsb.2019.07.007_bib22","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1021\/acs.jafc.5b05156","article-title":"Inhibitory effects of 4'-demethylnobiletin, a metabolite of nobiletin, on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mouse ears","volume":"63","author":"Wu","year":"2015","journal-title":"J Agric Food Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519304769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519304769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:41:09Z","timestamp":1761928869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383519304769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2211383519304769"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2019.07.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}